SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?


To: jake burns who wrote (1369)6/3/1999 1:26:00 AM
From: Stanley G.  Read Replies (1) | Respond to of 1510
 
"Yes, to ever...but I don't know what the next 6 months will bring. "

Better hope it does not come close to it's book value or worse below it's book value of $1.10 / share

(DBC)

dbc.com

This stock should go below $5.00 / share
If it hits $4.00 wait for $3.00 then $2.00 then????

Can anybody quote where IMNR ever had a profitable quarter and why.